Evaluation Of New Four Haptic Intraocular Lens (Pearlens 4H)
Published 2026 - 44th Congress of the ESCRS
Reference: POCAT431 | Type: Poster | DOI: 10.82333/8av3-n183
Authors: Dr Hussien Ismail* 1 , Prof. Dr Mahmoud Ismail 2
1Cornea,Nour El Hayah Eye Hospital,Cairo,Egypt, 2Ophthalmology,Al Azhar University,Cairo,Egypt
Purpose
To assess the new cutting edge 4 Haptic Design Pearlens 4H Hydrophobic Acrylic Intraocular Lens, locally manufactured in Cairo, Egypt. Regarding quality, clinical biocompatibility, and complications.
Setting
Nour El Hayah Eye Hospital, Cairo, Egypt. at a time from October 2025 to March 2026.
Methods
This prospective, interventional research involved twenty six eyes with senile cataracts operated by phaco-emulsification and implantation of IOL (Pearlens 4H).
There were 15 (57.7%) males and 11 (42.3%) females.
The operated eyes were 12 (46.2%) right eye (OD) and 14 (53.8%) eyes were left (OS).
Patients were examined preoperatively, 24 Hours Post Op, 1 week post op, 1 Month post Op, 3 Months Post Op, and 6 months Post OP.
Results
All Cases went smoothly with no intraoperative complications.
All Patients were going smoothly and did not experience any post operative complications during all the Post Operative Follow Ups.
The present research found that there was no PCO incidence found among all 26 cases at all Follow Ups including 3 and 6 months postoperatively.
Conclusions
This research demonstrated that the optical quality of Pearlens 4H IOL has satisfactory results and significant improvement in regards to the incidence of PCO formation, flare reaction, cell deposits, cystoid macular edema, aberrations, stability, and visual acuity.